Bayesian estimation of cognitive decline in patients with Alzheimer's disease

Canadian Journal of Statistics

Volumn 30, Issue 1, 2002, Pages 37-54

  Bélisle, Patrick ^a   Joseph, Lawrence ^a   Wolfson, David B ^a   Zhou, Xiaojie ^a  

^a MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

Alzheimer's disease; Bayes factors; Biphasic regression; Change point; Gibbs sampler; Mini Mental State Exam

Indexed keywords

EID: 0036016750     PISSN: 03195724     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Posterior Bayes factors (with discussion)
2. Temporal quantification of Alzheimer's disease severity: "Time index" model
3. Quantifying surprise in the data and model verification (with discussion)
4. The methodology of studying decline in Alzheimer's disease
5. The Canadian study of health and aging: Risk factors for Alzheimer's disease in Canada
6. Bayesian model choice via Markov chain Monte Carlo methods
7. Hierarchical Bayesian analysis of changepoint problems
8. Marginal likelihood from the Gibbs output
9. Sensitivity of the fractional Bayes factor to prior distributions
10. Alternative Bayes factors for model selection
11. "Mini-mental state:" A practical method for grading the cognitive state of patients for the clinician
12. Sampling-based approaches to calculating marginal densities
13. Inferences from iterative simulation and multiple sequences (with discussion)
14. Individual trajectories of cognitive decline in patients with dementia of the Alzheimer type
15. A 5-year longitudinal study of the mini-mental state examination in normal aging
16. The cost effectiveness of Douepezil therapy in Swedish patients with Alzheimer's disease: A Markov model
17. Bayes factors in practice
18. Bayes factors
19. Comparison of rate of annual change of mental status score in four independent studies of patients with Alzheimer's disease
20. Bayesian model choice: What and why? (with discussion)
21. Random effects models for longitudinal data
22. Hierarchical Bayes models for the progression of HIV infection using longitudinal CD4 T-cell numbers. (With discussion.)
23. A functional decline model for prevalent cohort data
24. Efficiency of tacrine and lecithin in mild to moderate Alzheimer's disease: Double blind trial
25. Predictors of cognitive and functional progression in patients with probable Alzheimer's disease
26. How many iteration in the Gibbs sampler?
27. Bayesian computation via the Gibbs sampler and related Markov chain Monte Carlo methods (with discussion)
28. Modelling disease progression with Markov models
29. Cognitive decline in Alzheimer's disease: A longitudinal investigation of risk factors for accelerated decline
30. Rates of change of common measures of impairment in senile dementia of the Alzheimer type